ABN AMRO Investment Solutions’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
ABN AMRO Investment Solutions's BIIB Position: Q2 2026 in Review
ABN AMRO Investment Solutions increased its Biogen (BIIB) stake by 34% in Q2 2026, buying an estimated $394K and bringing the position to 8,037 shares worth $1.74M. The position accounts for 0.02% of the portfolio, ranked #435.
ABN AMRO Investment Solutions first reported a position in BIIB in Q1 2023 and has held it in 7 quarters since. The position peaked at $3.96M in Q3 2023. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- ABN AMRO Investment Solutions held 8,037 shares of Biogen worth $1.74M as of Q2 2026.
- ABN AMRO Investment Solutions bought 2,061 Biogen shares in Q2 2026, an estimated $394K.
- Biogen made up 0.02% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #435 holding.
- ABN AMRO Investment Solutions first reported a position in Biogen in Q1 2023 and has held it in 7 quarters since.
- ABN AMRO Investment Solutions's Biogen position peaked at $3.96M in Q3 2023.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.